Private Insurance Coverage of Infused Chemo Varies by Setting

Share this content:
Private Insurance Coverage of Infused Chemo Varies by Setting
Private Insurance Coverage of Infused Chemo Varies by Setting

FRIDAY, Feb. 23, 2018 (HealthDay News) -- From 2004 to 2014, there was an increase in the provision of infused chemotherapy in hospital outpatient departments (HOPDs), which is associated with increased spending, according to a research letter published online Feb. 22 in JAMA Oncology.

Aaron N. Winn., Ph.D., from the Medical College of Wisconsin in Milwaukee, and colleagues describe trends in use of and spending for infused cancer chemotherapy in HOPDs versus physician office settings from 2004 to 2014. Data were included for 283,502 commercially insured patients who initiated treatment with infused chemotherapy and remained enrolled for six months.

The researchers found that from 2004 to 2014, there was an increase in the rate of commercially insured patients receiving infused chemotherapy in HOPDs, from 6 to 43 percent of infusions. At the drug level, spending was significantly lower in offices versus HOPDs ($1,466 versus $3,799). Patients treated in offices had lower day-level spending ($3,502 versus $7,973). During the six-month treatment-episode, total reimbursement was also lower in offices ($43,700 versus $84,660). Similar results were seen in sensitivity analysis on breast cancer patients.

"Potential targets for reduction of excess spending and creation of a more efficient health care system can come from private insurers following Medicare's lead, which has started to equalize payments across sites of care," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WPSI Recommends Annual Urinary Incontinence Screening

WPSI Recommends Annual Urinary Incontinence Screening

Due to limited evidence, other experts urge caution in implementing guideline for women

Young, Growing Athletes at High Risk for ACL Injuries

Young, Growing Athletes at High Risk for ACL ...

Athletic teams should provide program that includes muscle strengthening, proper technique training

Side Effects of Biologics for Rheumatic Dz May Up Anxiety

Side Effects of Biologics for Rheumatic Dz May ...

Common patient concerns are risks of cancer and tuberculosis activation

is free, fast, and customized just for you!




Already a member?

Sign In Now »